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Abstract
Background: Over the last 30 years the number of people who drink alcohol at harmful levels has increased in
many countries. There have also been large increases in rates of sexually transmitted infections. Available evidence
suggests that excessive alcohol consumption and poor sexual health may be linked. The prevalence of harmful
alcohol use is higher among people attending sexual health clinics than in the general population, and a third of
those attending clinics state that alcohol use affects whether they have unprotected sex. Previous research has
demonstrated that brief intervention for alcohol misuse in other medical settings can lead to behavioral change,
but the clinical- and cost-effectiveness of this intervention on sexual behavior have not been examined.
Methods: We will conduct a two parallel-arm, randomized trial. A consecutive sample of people attending three
sexual health clinics in London and willing to participate in the study will be screened for excessive alcohol
consumption. Participants identified as drinking excessively will then be allocated to either active treatment (Brief
Advice and referral for Brief Intervention) or control treatment (a leaflet on healthy living). Randomization will be via
an independent and remote telephone randomization service and will be stratified by study clinic. Brief Advice will
comprise feedback on the possible health consequences of excessive alcohol consumption, written information
about alcohol and the offer of an appointment for further assessment and Brief Intervention. Follow-up data on
alcohol use, sexual behavior, health related quality of life and service use will be collected by a researcher masked
to allocation status six months later. The primary outcome for the study is mean weekly alcohol consumption
during the previous three months, and the main secondary outcome is the proportion of participants who report
unprotected sex during this period.
Discussion: Opportunistic intervention for excessive alcohol use has been shown to be effective in a range of
medical settings. The SHEAR study will examine whether delivering such interventions in sexual health clinics results
in reductions in alcohol consumption and will explore whether this is associated with changes in sexual behavior.
Keywords: Alcohol misuse, Intervention, Randomized controlled trial, Sexual health, Effectiveness
Background
Concerns have been raised regarding increased levels of
alcohol consumption in many countries [1]. It is esti-
mated that as many as one in five adults drink too much
alcohol in the UK [2]. This may take the form of sus-
tained excessive consumption or episodic bouts of
‘binge’ drinking. Excessive alcohol consumption can lead
to a range of physical and mental health problems, which
result in increased use of healthcare services and costs to
society associated with sickness absence, unemployment,
accidents and crime [3].
The proportion of people who drink excessively has
increased considerably over the last 30 years, especially
among people aged under 25 [4]. Increasing levels of al-
cohol misuse have been accompanied by large increases
in rates of sexually transmitted infections [5]. The fig-
ures published by the Health Protection Agency (HPA)
in 2010 showed a record level of nearly half a million
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new diagnoses. While we do not know if alcohol use is
implicated in this increase, epidemiological data suggest
that it may be. For instance, cross-sectional data from a
sample of over 1,000 young people in nine European cit-
ies demonstrated that alcohol consumption was asso-
ciated with the number of sexual partners and age at first
sexual contact [6]. In the United States, changes in the
price of alcohol in the 1980s and 1990s were highly corre-
lated with changes in rates of gonorrhoea [7]. Policies
which succeeded in reducing drunk driving rates in
young men in the United States were associated with sub-
sequent reductions in gonorrhoea rates among young
males [8]. Further evidence to support an association be-
tween alcohol consumption and sexual behavior comes
from cross-sectional surveys, which have also demon-
strated high levels of alcohol consumption among people
attending sexual health clinics [9-11]. In one study, over a
third of participants indicated that their attendance was
alcohol related [10].
Systematic reviews of brief interventions for alcohol
misuse have shown that they lead to clinically important
reductions in alcohol consumption across a range of
healthcare settings [12,13]. Interventions delivered in a
single session appear to be as effective as more lengthy
ones [14]. Stepped interventions in which people receive
interventions of greater intensity depending on the ex-
tent of their needs have also demonstrated positive
effects [15,16].
To date, there has been only one randomized trial of
brief intervention for alcohol misuse in a sexual health
setting [17]. In this study, half of a total sample of 184
people found to be drinking excessively was offered a
brief intervention delivered by one of two trained nurses.
At a three-month follow-up 62 % of those that received
the brief intervention reported consuming less alcohol
compared to 47 % of those in the control arm of the
trial. While this study demonstrated the feasibility of a
randomized trial of brief alcohol intervention for people
attending sexual health clinics, the intervention was
delivered by a research nurse, rather than those already
working in the clinic, limiting the generalizability of the
study findings. In addition, the impact of brief interven-
tion on sexual health outcomes was not explored and
the costs and cost-effectiveness of the intervention were
not examined. There is widespread recognition of the
need for experimental studies to examine the clinical
effects and cost-effectiveness of screening and brief inter-
vention for alcohol misuse for people who attend sexual
health clinics [18].
Research objectives
The aim of the SHEAR study (Sexual Health and Exces-
sive Alcohol: Randomized trial) is to examine the effect-
iveness and cost-effectiveness of opportunistic brief
intervention for alcohol misuse for people who attend
sexual health clinics and consume excessive alcohol. To
achieve this aim we will:
1. Test whether brief intervention reduces subsequent
alcohol consumption measured six months later
compared to the control treatment.
2. Examine whether brief intervention compared to
control treatment is associated with changes in sexual
behavior.
3. Examine the cost-effectiveness of brief intervention
compared to control treatment.
Hypotheses
i. Brief intervention for those attending sexual health
clinics and drinking excessively reduces mean weekly
alcohol consumption over a 12-week period prior to
the 6-month follow-up interview (that is, weeks 13
to 24 after intervention).
ii. Brief intervention for those attending sexual health
clinics and drinking excessively reduces the
likelihood of unprotected sexual intercourse over a
12-week period prior to the 6-month follow-up
interview.
iii. Brief intervention for those attending sexual health
clinics and drinking excessively is more cost-effective
than control treatment.
Methods/Design
The design is a two parallel-arm, single-blind, individu-
ally randomized controlled trial. The trial will be an inte-
grated clinical and economic evaluation and will
compare the intervention versus control treatment on al-
cohol consumption, sexual behavior, health-related qual-
ity of life and costs in the six months following
randomization. We will also conduct a parallel process
evaluation, which will include an examination of the up-
take of study interventions and an analysis of qualitative
data from in-depth interviews with a sample of service
users and providers. These data will help us to examine
the uptake and acceptability of the interventions being
used and explore the relationship between the study con-
text and outcomes.
Study setting
Study participants will be recruited from three sexual
health clinics in London. Collectively, these clinics serve
a diverse population with high levels of alcohol misuse
and poor sexual health [19,20].
Recruitment
At each clinic where we recruit participants, information
about the study will be displayed on posters in waiting
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rooms. On days when recruitment is taking place, clinic
staff will hand all those attending the service a postcard
with information about the study and ask people if they
would be willing to meet a researcher. If they agree to
this, a researcher will explain the rationale for the study
and give them a copy of the Patient Information Leaflet.
The Patient Information Leaflet states that we are con-
ducting a study about ‘sexual health and lifestyle advice’
and only refers to alcohol in the context of other aspects
of lifestyle, such as exercise, diet and smoking. The re-
searcher will encourage potential participants to spend
as much time as they want asking questions about the
study and considering whether they wish to take part or
not. Before any trial specific procedures are performed,
the patient will sign and date the Informed Consent
Form. For those willing to provide consent, eligibility to
participate in the study will be assessed and baseline
clinical and demographic data will be collected. Potential
participants will be asked five questions on ‘health and
lifestyle’. We will check with participants the contact
details they have given to clinic staff to make sure they
are correct. We will ask participants for other informa-
tion that may assist follow-up and seek written informed
consent to contact their general practitioner solely for
the purpose of helping us collect follow-up data. A re-
cruitment flow chart is presented in Figure 1.
Randomization
Those who are eligible will be randomized to brief inter-
vention or control treatment. The researcher will provide
those who are ineligible with written information about
health and lifestyle. Remote telephone randomization
will be undertaken through a fully automated telephone-
based service operated by an independent Clinical Trials
Unit. Equal numbers of participants will be randomized
to each arm of the trial. We will use permuted blocks
stratified by the clinic, with block size randomly assigned
to between four and six. The researcher will notify the
treating clinician concerning which arm of the trial they
are in. This researcher will play no part in the collection
of follow-up data.
Follow-up
Three months after randomization, study participants
will receive a phone call, text message or an email thank-
ing them for taking part in the study, reminding them
that they will be contacted in three months’ time to
complete the follow-up interview, and asking them to let
us know whether their contact details are likely to
change during this period. If, at six months, our attempts
to contact a participant are unsuccessful, we will check
their contact details against those given during any sub-
sequent visits to the clinic. If the participant provided
consent for us to contact their general practitioner, a
family member or friend we will contact them to obtain
updated contact details for the participant. Follow-up
interviews will be carried out by telephone, unless the
participant requests a face-to-face interview. Any face-
to-face interview will take place at the clinic at a time
which is convenient for the participant. Any travel costs
or other reasonable expenses incurred by the participant
will be reimbursed. All participants will be offered a £15
honoraria after completion of the six-month follow-up
interview.
Planned interventions
We will test the effects of Brief Advice and referral deliv-
ered by the treating clinician. The intervention is based
on that used in a previous trial conducted in an emer-
gency medical setting [15]. The intervention consists of:
 Confirming the current level of alcohol use and brief
feedback that alcohol use at that level has the
potential to harm health
 Making a link between alcohol and clinic attendance
 Written information on alcohol and health in the
form of a leaflet recommended by the Department of
Health: ‘How much is too much’ [21]
 The offer of an appointment with an Alcohol Health
Worker (AHW).
This form of intervention was previously tested in a
feasibility study in a sexual health clinic and found to be
acceptable to clinicians working in this busy clinical set-
ting [9].
On days when participants are recruited from the
clinics, an Alcohol Health Worker will be available to see
those who are willing to receive further help. Brief Inter-
vention delivered by the AHW will last up to 30 minutes
and use the ‘FRAMES’ approach [14,22]. For any partici-
pant who is drinking at a harmful or dependent level,
the AHW will have the option of arranging a follow-up
appointment or referring them on to local alcohol ser-
vices for individual alcohol counseling, detoxification
and so on. In the event that the participant is unable to
attend an appointment that day they will be offered an
appointment on a later date or telephone-based support
and advice.
Control treatment
Those randomized to control treatment will be offered a
copy of the leaflet ‘Five Choices to Help You Stay
Healthy’ [23], which provides general information on
preventative health, including alcohol use, diet, exercise,
cigarette smoking and details of how to obtain further
information about health and lifestyle.
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Treatment integrity
Treatment integrity will be maximized through training,
supervision and checks on written notes kept by clini-
cians and Alcohol Health Workers. All clinicians who
deliver the brief intervention will receive training in ac-
cordance with Department of Health guidelines (www.
alcohollearningcentre.org.uk). All Alcohol Health Work-
ers who take part in the study will be experienced practi-
tioners who have undertaken specific training in
counseling people who misuse alcohol. All Alcohol
Health Workers will receive regular clinical supervision.
Clinical supervisors will encourage Alcohol Health
Workers to discuss work with trial participants along
with other patients they see.
Front-line clinicians will be asked to complete a short
tick box proforma for each study participant to indicate
whether the four components of the Brief Advice and
referral are delivered. Alcohol Health Workers will be
asked to complete a longer proforma which will record
the number and length of session(s), interventions deliv-
ered during the session(s) and further information on
referrals that were subsequently made. The proforma is
based on that used to assess treatment fidelity in our
previous trial of brief intervention in the Accident and
Emergency Department [15]. At the end of the study, we
will inspect a random sample of 20% of all study pro-
forma to identify the proportion of people in the experi-
mental arm of the trial who receive the interventions
they were allocated.
Planned inclusion/exclusion criteria
To maximize generalizability of study findings, we have
kept our inclusion criteria broad and limited our exclu-
sion criteria. To participate in the study people must be
Excluded:
Aged under 19
Not misusing alcohol
according to M-SASQ
Unwilling to provide written
informed consent to
Allocated brief intervention
(Including offer of appointment with
Allocated control treatment (Leaflet
on health and lifestyle)
Lost to follow-up at six month Lost to follow-up at six months
Data collected and analysed on
alcohol consumption, sexual health, 
quality of life and service utilisation
Data collected and analysed on
alcohol consumption, sexual health,
quality of life and service utilisation
Enrolm
ent
Allocation
Follo
w
up
Analysis
Complete collection of baseline data
on sexual behaviour and health-
related quality of life
People attending sexual health clinics
provided withi nformation and
assessed for eligibility using the
Modified-Single Alcohol
Randomised by researcher who
informs treating clinician who delivers
brief intervention
Figure 1 Recruitment flow diagram.
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aged 19 years or above, be drinking excessively according
to the Modified-Single Alcohol Screening Question [24]
and be willing to provide written informed consent to
take part in the study. The age limit is because people
younger than 19 years attending sexual health clinics re-
ceive health advice. We will exclude any person who is
unable to communicate in English sufficiently to
complete baseline questionnaires, anyone who does not
have an address or contact telephone number, and any-
one who believes they may not be contactable in six
months’ time.
Measures
Baseline measures
Basic demographic data on age, gender, and ethnicity will
be extracted from clinic records and checked with the
patients to make sure they are correct.
All patients consenting to take part will be asked to
complete a computer-assisted self-completion interview
[25,26].
Alcohol consumption will be assessed using the
Modified-Single Alcohol Screening Question (M-SASQ).
The M-SASQ is a brief validated measure of harmful al-
cohol use that is acceptable to patients in general med-
ical settings [24]. It consists of a single question - for
men: ‘How often do you drink more than eight units of
alcohol on one occasion?’ and for women: ‘How often do
you drink more than six units of alcohol on one occa-
sion?’ To help people answer this question they are
shown a card which describes what a unit of alcohol is.
Those drinking at such levels once a month or more are
considered eligible. The question on alcohol is embedded
in a series of four other questions asking about diet, ex-
ercise and smoking.
In addition, eligible patients will be prompted to answer
questions on their sexual behavior and health-related qual-
ity of life (EuroQol 5 Dimensions (EQ-5D) [27]).
Follow-up measures
Follow-up data will be obtained by a telephone interview
by a researcher who is masked to the participant’s alloca-
tion status.
Alcohol consumption data in the last 90 days will be
collected using the Form 90. The Form 90 is a validated
alcohol consumption assessment tool which provides a
detailed day-by-day account of alcohol use in the 90 days
prior to the interview [28].
In addition, participants will be asked about hazardous
drinking (Alcohol Use Disorders Identification Test-
Consumption (AUDIT-C) [29]), sexual behavior in the
last three months, health-related quality of life (EQ-5D
[27]) and resource use during the previous six months
(Adult Service Use Schedule [30]).
Outcomes
1. Primary: Mean weekly units of alcohol consumed
during the previous 90 days using the Form 90 [28].
2. Main secondary: Whether or not the participant has
had unprotected sex in the last three months.
3. Other secondary: Mean units consumed per drinking
day and percentage days abstinent, both measured
using the Form 90, and whether or not the
participant is drinking alcohol at hazardous levels
using the AUDIT-C [29].
Our secondary sexual behavior outcomes are based on
those used in a previously reported study [31] and will
comprise: total number of sexual partners during the last
three months, any incidence of regretted sex in the last
three months, number of people they had unprotected sex
with (anal or vaginal sex without a condom) in the three
months before the interview, any incidence of unprotected
sex while drunk in the last three months, how long they
knew their last sexual partner before they had sex with
them, unwanted pregnancy and any new diagnosis of a
sexually transmitted infection in the last three months.
Sample size
Initial sample size calculations were based on compari-
son of the primary outcome. In order to achieve 80%
power to detect a mean weekly difference of 23.4 units
of alcohol consumption with standard deviation of 58
units [15], 97 evaluable participants per arm were
needed. An inflation factor of 1.15 for clustering by clin-
ician in the intervention arm was considered [32], based
on an intracluster correlation coefficient of 0.04 [33] and
a cluster size of 7 in the intervention arm. Together with
an anticipated 30 % drop-out rate at six months, the ini-
tial recruitment target was, therefore, 160 per arm.The
first months of the trial showed that recruitment and re-
tention rates were higher than expected; the sample size
was, therefore, modified to provide additional power to
test both the primary and main secondary hypotheses (a
reduction in unprotected sexual intercourse) of interest.
The final sample size was based on a practical size of
380 per arm (760 in total). If 65% of participants had un-
protected sex in the control group compared to 50% in
the intervention arm, the power to detect such an effect
would be above 90%, assuming a 25% drop out, and a
clustering design effect of 1.15. The power would remain
above 80% if the absolute difference is 13%.
Statistical analysis
Baseline characteristics will be reported by treatment
arm. The primary outcome will be analyzed using
random-effects linear regression adjusted for age, sex
and harmful alcohol use measured at baseline, testing for
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the presence of an intervention effect between the two
arms. The random-effects model will take into account
clustering by sexual health clinic and, in the intervention
arm, by treating clinician [34].
Alcohol consumption is not expected to be normally dis-
tributed and particular care will be taken to check the val-
idity of the regression, including normality and
homoscedasticity of the residuals. If the assumptions are
violated, sensitivity analysis will be performed as
appropriate.
Participants who dropped out from the trial will be
compared to the completers. Sensitivity of the results to
missing data will be assessed by performing multiple
imputations; further models allowing for missing not at
random mechanism will also be considered [35].
The main secondary outcome will be compared in the
same way as the primary, using logistic regression and
adjusting for unprotected sex at baseline. Other secondary
outcomes will be compared using linear or logistic regres-
sion, and adjusted for baseline value, as appropriate.
In order to assess for possible heterogeneity of the
intervention effect, primary and main secondary out-
comes will also be reported by the following subgroups:
gender, age (<25, 25 to 35, 35 and older), ethnicity (white
vs. other), sexual orientation (heterosexual vs. other). All
analyses will be performed according to the
randomization arm (intention-to-treat), and two-sided P-
values considered significant when below 0.05.
The economic evaluation will take the NHS/Personal
Social Services perspective preferred by the National In-
stitute for Health and Clinical Excellence [36] and shown
to be the key cost sectors in our previous research of
brief intervention for alcohol misuse [30]. Data on up-
take of the brief intervention will be collected from
records to avoid patients revealing their treatment group
to the research assessors. Data on indirect time, includ-
ing preparation and supervision, will be collected directly
from the treating clinician. Data on the use of other
health and social services will be collected using the
Adult Service Use Schedule (AD-SUS) adapted for alco-
hol misuse in previous research [30]. The cost of the
brief intervention will be directly calculated from salaries
using a micro-costing approach [37]. National UK unit
costs will be applied to medication, hospital contacts and
community health and social services [38,39].
Differences in mean costs will be analyzed using standard
parametric t-tests with the validity of results confirmed
using bias-corrected, nonparametric bootstrapping (repeat
re-sampling) [40]. Despite the skewed nature of cost data,
this approach is recommended to enable inferences to be
made about the arithmetic mean [41]. Cost-effectiveness
will be assessed through the calculation of incremental cost-
effectiveness ratios [42] and will be explored in terms of al-
cohol consumption (primary economic analysis) and quality
adjusted life years (QALYs) using the EQ-5D measure of
health-related quality of life (secondary economic analysis).
Uncertainty around the cost and effectiveness estimates will
be represented by cost-effectiveness acceptability curves
[43].
Ethical issues
Approval for the study was obtained from West London
Research Ethics Committee 3 (10/H0706/29) and The
Research and Development departments of Chelsea and
Westminster Hospital NHS Foundation Trust and Im-
perial College Healthcare NHS Trust prior to the start of
data collection at each local clinic. Only those who agree
to provide written informed consent will be included in
the study. Each potential participant will be provided
with a copy of an information sheet that includes a con-
tact number for the study team.
Discussion
The SHEAR study is the first large-scale randomized trial
to examine the clinical and cost-effectiveness of brief
intervention for alcohol misuse for people attending sex-
ual health clinics. We are testing a very brief approach to
screening and intervention that is aimed at accurately
identifying people who are drinking excessively and help-
ing them reduce their drinking while minimizing any dis-
ruption to normal clinical practice. The use of a short
(single-item) screening question may have other benefits.
It has been argued that previous trials of brief interven-
tion for excessive alcohol use may underestimate the im-
pact of ‘active’ treatment because the process of
assessing alcohol use may itself highlight this issue and
prompt people to reflect on and consider reducing the
amount they drink [44]. In the SHEAR study all material
used to publicize and recruit participants refers to alco-
hol in the context of other lifestyle factors that affect
health, such as smoking and diet. We believe that this
approach better represents the absence of enquiry or in-
formation about alcohol that people currently receive in
this and other medical settings, thus allowing us to
examine the full impact associated with the brief inter-
vention we are testing.
The form of Brief Advice and referral that we are using
is offered to participants after their main health concerns
have already been met [45] and includes a brief state-
ment about health consequences of alcohol use, an ap-
proach which has been demonstrated to increase uptake
of brief alcohol interventions [46]. While this form of
intervention has been shown to be acceptable to patients
in other settings, we know very little about acceptability
in sexual health clinics. We will use quantitative data on
levels of uptake of interventions and qualitative data
from in-depth interviews with service users and provi-
ders to examine the acceptability of screening and Brief
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Advice to people who are found to be drinking exces-
sively in this setting.
In addition to being large enough to demonstrate
reductions in alcohol consumption of a magnitude seen
in previous trials, the relatively large sample size means
that we have sufficient power to examine clinically im-
portant changes in sexual behavior associated with this
intervention. While reducing the level of alcohol misuse
is worthwhile, the widespread uptake of brief interven-
tion across sexual health clinics may require evidence
that any change in drinking are associated with changes
in sexual behavior [18]. However, we are only collecting
data from people attending three sexual health clinics in
London. The findings might not be generalizable to
those in rural areas or people with different cultural and
socioeconomic backgrounds.
The study faces a number of important challenges, in-
cluding the need to ensure the fidelity of a brief inter-
vention delivered by over 30 clinicians working across
three different clinics, and the need to achieve a high
follow-up rate in a relatively young and mobile study
population. If we are able to meet these challenges, we
will generate data about the clinical- and cost-
effectiveness of a form of brief screening and interven-
tion that has the potential to be delivered more widely
across sexual health clinics and help establish whether
the previously reported association between high alcohol
consumption and poor sexual health is a causal one.
Trial status
Recruitment is on-going (800 participants recruited as of
end of April 2012).
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